Leslie Thompson studies point to new targets for Huntington’s disease treatments

Leslie Thompson

UCI MIND’s Leslie Thompson has worked on Huntington’s disease for over two decades, and her group’s research has revealed extensive insights into the biological underpinnings of the disease. During the week of July 15, her laboratory adds to its impressive log of discoveries. more >



UCI Staffer Co-Founds Support Group for Huntington’s Disease Research and Care

phpThumb_generated_thumbnailjpg

To learn more about HD CARE and co-founder, Frances Saldaña, click here. more >



UCI Brings Ask the Doc to Laguna Woods

Ask the Doc Age Well

On May 29, 2013, the UCI Institute for Memory Impairments and Neurological Disorders will offer its popular Ask the Doc forum at Laguna Woods Village.

Date and Time: May 29, 2013 from 1-3 pm
Location: Laguna Woods Village, Clubhouse 3, 23822 Avenida Sevilla, Laguna Woods, CA 92637
RSVP: Individuals who are not residents of Laguna Village must RSVP at (949) 824-2382, press option 4, and leave a message or email mpsoares@uci.edu

Our  Ask the Doc flyer provides event details and directions. more >



Family Education Series Available Online

The Family Education Series, taught by Dr. Malcolm Dick, Senior Neuropsychologist at the UCI MIND Memory Assessment and Research Center, and Dr. Cordula Dick-Muehlke, Director of Education at UCI MIND, is now available online.  Workshops available for viewing are Alzheimer’s Disease and Other Dementias: What Does the Diagnosis Mean? more >



Lack of Research Volunteers Slows Progress in Alzheimer’s Disease

 

  more >



More Evidence that Omega-3 Fatty Acids Support Brain Health

A study published in the February 28 issue of the journal Neurology provides more evidence that high dietary consumption of omega-3 fatty acids, found in fish such as salmon and tuna, may protect the brain against cognitive impairment.

The research team, led by Dr. more >



Cancer drug rapidly clears amyloid plaques

Researchers at Case Western Reserve University School of Medicine have demonstrated that bexarotene, an FDA-approved drug for the  treatment of skin cancer, dramatically and rapidly clears amyloid plaques from the brains of mice bred with Alzheimer’s disease.  Led by Gary Landreth, Ph.D.,  the study just published on line in Science Express, found that bexarotene not only enhanced clearance of beta amyloid, an abnormal protein associated with Alzheimer’s disease, but also improved some cognitive and behavioral functions. more >



UCI Teaser Video

http://vimeo.com/33187876

Trailer video for the full version of a documentary that looks at what UCI is doing to fight Alzheimer’s disease.